| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Odnass | Redefining Early Cancer Detection Odnass is developing a next-generation blood test designed to detect multiple cancers at their earliest, pre-symptomatic stage. What sets Odnass apart The Odnass platform is intended for population-level screening, monitoring of high-risk individuals, occupational exposure programs, and integration with traditional screening pathways. Following the filing of its provisional patent in 2025, Odnass is advancing through its Proof-of-Concept phase, focusing on technology validation, expansion of its intellectual property portfolio, and strategic partnerships within the global diagnostics ecosystem. Our vision: a world where cancer is detected earlier, treatment begins sooner, and survival outcomes improve for millions. |
| Category: | Blockchain, Health & biotech |
| URL: | www.odnass.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2023 |
| Address: | 280 Bannister Rd, Unit 6, Canning Vale, Western Australia 6155, AU |
| State: | Western Australia |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://au.linkedin.com/company/odnass-pty-ltd |
| Founders: |
No items found
|
| Awards won: | |
